What are the poor prognostic factors in eosinophilic granulomatosis with polyangiitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Poor Prognostic Factors of EGPA

Cardiac involvement is the most critical poor prognostic factor in EGPA, followed by renal disease, gastrointestinal involvement, central nervous system disease, and age ≥65 years—all of which are independently associated with increased mortality. 1, 2, 3

Organ-Specific Poor Prognostic Factors

Cardiac Involvement (Highest Mortality Risk)

  • Symptomatic cardiomyopathy carries the strongest association with death 4
  • Cardiac disease increases in-hospital mortality nearly 2-fold (OR: 1.94) 2
  • Major vascular events and cardiac involvement are frequent in EGPA and associated with poorer survival 1
  • Postinflammatory cardiac fibrosis independently predicts mortality 4
  • Cardiac involvement is more common in ANCA-negative patients 1

Renal Disease (Second Highest Risk)

  • Renal involvement increases in-hospital mortality 5-fold (OR: 5.20), the highest odds ratio among organ systems 2
  • Glomerulonephritis occurs more frequently in ANCA-positive patients 1
  • Renal disease is a component of the Five-Factor Score (FFS) for poor prognosis 5

Gastrointestinal Involvement

  • GI disease increases in-hospital mortality 3-fold (OR: 3.05) 2
  • Part of the FFS poor-prognosis criteria 5
  • More common in ANCA-negative phenotype 1

Central Nervous System Involvement

  • CNS disease increases mortality risk nearly 3-fold (OR: 2.91) 2
  • Distinct from peripheral neuropathy, which paradoxically may indicate better prognosis 3

Pulmonary Complications

  • Interstitial lung disease increases mortality 2.6-fold (OR: 2.62) 2
  • Alveolar hemorrhage is more common in ANCA-positive patients 1
  • Severe or uncontrolled asthma at diagnosis predicts worse respiratory outcomes 1

Clinical and Laboratory Factors

Age

  • Age ≥65 years is the only demographic factor independently associated with higher risk of death during follow-up 6
  • Older age at onset correlates with increased mortality 4

ANCA Status and Phenotype

  • MPO-ANCA positivity predicts higher relapse rates (41% of patients experience ≥1 relapse) 6
  • ANCA-positive patients have more vasculitic manifestations (glomerulonephritis, peripheral neuropathy, purpura) 1
  • Overall survival appears worse in ANCA-negative patients, likely due to higher cardiac involvement 1
  • Baseline eosinophilia <3000/mm³ paradoxically increases relapse risk 6

Disease Severity Markers

  • Advanced EGPA severity at presentation (higher FFS) predicts mortality 4
  • Higher disease activity scores correlate with worse outcomes 4
  • Disturbance of consciousness on admission indicates severe disease 3
  • Unscheduled/emergent admission associated with higher mortality 3

Infectious Complications

  • Infection increases in-hospital mortality nearly 4-fold (OR: 3.87) 2
  • Sepsis is an independent predictor of death 3
  • Risk is disease-related and amplified by immunosuppressive therapy 1

Important Clinical Nuances

Protective Factors (Lower Mortality)

  • Female gender shows lower mortality in some cohorts 3
  • Peripheral neuropathy, despite causing disability, is associated with lower mortality 3
  • Chronic sinusitis and asthma requiring prolonged low-dose corticosteroids correlate with better survival, though these patients have higher relapse rates 4

Relapse Patterns

  • 41% of patients experience relapses, typically 26 months after treatment onset 6
  • 57% of relapses occur when corticosteroid tapering reaches <10 mg/day 6
  • Relapses themselves do not impact mortality 4
  • Immunosuppressive therapy and prolonged corticosteroid use increase relapse risk 4

Clinical Pitfalls to Avoid

  1. Do not underestimate cardiac risk in ANCA-negative patients—they have higher rates of cardiomyopathy despite less vasculitic features 1

  2. Peripheral neuropathy should not be equated with poor prognosis—unlike cardiac, renal, or GI involvement, it predicts better survival despite causing significant disability 3

  3. Normal eosinophil counts do not exclude active disease or relapse—eosinophil levels correlate poorly with disease activity during follow-up 1

  4. Asthma severity is a double-edged sword—while requiring chronic corticosteroids increases relapse risk, it paradoxically associates with better overall survival 4

Monitoring Recommendations

Based on the 2023 Nature Reviews Rheumatology guidelines 1:

  • Periodic echocardiography and electrocardiography in all patients for early cardiac detection
  • Cardiac MRI only in patients with overt cardiomyopathy
  • Close lung function monitoring, especially in overweight patients, those with pulmonary infiltrates, or severe asthma
  • Neurological consultation for neuropathy management to prevent disability
  • Age-appropriate cancer screening, intensified in cyclophosphamide-treated patients
  • Bone density assessment in patients on prolonged glucocorticoids

References

2
Research

Nationwide Analysis of Eosinophilic Granulomatosis With Polyangiitis Hospitalizations.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2026

5
Research

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss).

Seminars in respiratory and critical care medicine, 2018

Related Questions

Which of the following statements are correct regarding Granulomatosis with Polyangiitis (GPA) and Eosinophilic Granulomatosis with Polyangiitis (EGPA)? a) Systemic (constitutional) symptoms occurring in more than 50% of cases are primarily associated with GPA. b) Ocular involvement occurs more frequently in EGPA. c) Peripheral nervous system involvement occurs less frequently in EGPA. d) Paranasal sinusitis occurs more frequently in EGPA. e) Asthma is a key feature of GPA.
When and how should plasma exchange (PLEX) be utilized in eosinophilic granulomatosis with polyangiitis (EGPA) with renal involvement?
In a patient with eosinophilic granulomatosis with polyangiitis (EGPA) who has late‑onset asthma, peripheral eosinophilia, and early‑onset diabetes, how should baseline and follow‑up spirometry be performed and interpreted to guide management?
What are hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA)?
What is the recommended treatment regimen for Churg‑Strauss syndrome (eosinophilic granulomatosis with polyangiitis)?
What is the current maintenance rituximab regimen for IgG4‑related disease of the meninges?
What is the condition called when loperamide use causes fecal impaction with bacterial trapping in the colon after a large bowel movement?
Could the combination of elevated mean corpuscular volume, elevated homocysteine, high transferrin saturation, high serum iron, and low ferritin indicate a bone marrow disorder, vitamin B12 deficiency, or another condition?
What are the salient features of hysteria (functional neurological symptom disorder)?
Is vitamin C supplementation safe in chronic kidney disease, and what is the recommended maximum dose?
Please write a SOAP note for a 54‑year‑old female presenting with painful oral ulcerations and tongue swelling.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.